StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Lipella Pharmaceuticals's price to sales ratio was 0.0× on Oct 19, 2026, against 4.1× a year earlier. Over the last 4 years it ranged from 0.0× to 76.1×, with a median of 6.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.0×−2.1
2025Dec 31, 20252.1×−4.7
2024Dec 31, 20246.9×−5.5
2023Dec 29, 202312.3×−34.3
2022Dec 30, 202246.7×–

More Lipella Pharmaceuticals figures

See a number that looks wrong?